Term | First occurrence | Definition |
---|---|---|
Clinical inertia | Phillips et al.. Ann Intern Med 2001,135:825–834. | Health care providers often do not initiate or intensify therapy appropriately during visits of patients with these problems [hypertension, dyslipidemia and diabetes]. We define such behavior as clinical inertia—recognition of the problem, but failure to act. |
Therapeutic inertia | Okonufa et al.. Hypertension 2006,3:345–351. | Therapeutic inertia (TI), that is, failure of providers to begin new medications or increase dosages of existing medications when an abnormal clinical parameter is recorded. |
Patient's inertia | Vinyoles. Hipertension 2007,24:91–92. | Three inertias are barriers to change: physician's inertia, patient's inertia, and health authorities inertia. |
(Translated from Spanish) | ||
Health authorities inertia | Vinyoles. Hipertension 2007,24:91–92. | Three inertias are barriers to change: physician's inertia, patient's inertia, and health authorities inertia. |
(Translated from Spanish) | ||
Physician inertia | Vinyoles. Hipertension 2007,24:91–92. | Three inertias are barriers to change: physician's inertia, patient's inertia, and health authorities inertia. |
(Translated from Spanish) | ||
Moser et al.. J Clin Hypertens 2009,11:1–4. | Physician inertia is defined as the failure to initiate therapy or to intensify or change therapy in patients with BP values >140 ⁄90 mmHg, or >130⁄80 mm Hg in hypertensive patients with diabetes, renal, or coronary heart disease. | |
Clinical Myopia | Reach. Diabetes Metab 2008,34:382–385. | We suggest that a failure to give preference to the long-term benefits of treatment intensification may represent a common mechanism underlying both patient non-adherence and physician clinical inertia. We dub such a failure as “clinical myopia”. |
Therapeutic momentum | Faria et al.. J Am Soc Hypertens 2009,3:267–276. | Therapeutic inertia, therapeutic momentum, and physician inertia are all terms synonymous with clinical inertia |
Rodrigo et al.. Int J Clin Pract 2013,67:97–98. | The reluctance to step down or withdraw therapy when further prescription is not needed or not supported by evidence. We have termed it ‘therapeutic momentum’. | |
Diagnostic inertia | Gil-Guillén et al.. Blood Press 2010,19:3–10. | Diagnostic inertia was defined as a failure to consider the diagnosis of HTN in a subject in the absence of diagnosis of HTN and elevated BP. |